MMP inhibitors can also significantly block the degradation of claudin-5 and angiotensin after focal cerebral infarction, thus alleviating BBB damage in the early periods of ischemic stroke (Benjamin and Khalil, 2012). This evidence concerns the gene CLDN5 and ischemic stroke.